These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32238378)

  • 1. GERD: A practical approach.
    Young A; Kumar MA; Thota PN
    Cleve Clin J Med; 2020 Apr; 87(4):223-230. PubMed ID: 32238378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory Heartburn: A Challenging Problem in Clinical Practice.
    Domingues G; Moraes-Filho JPP; Fass R
    Dig Dis Sci; 2018 Mar; 63(3):577-582. PubMed ID: 29352757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update on Functional Heartburn: Expert Review.
    Fass R; Zerbib F; Gyawali CP
    Gastroenterology; 2020 Jun; 158(8):2286-2293. PubMed ID: 32017911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians.
    Shaheen NJ; Weinberg DS; Denberg TD; Chou R; Qaseem A; Shekelle P;
    Ann Intern Med; 2012 Dec; 157(11):808-16. PubMed ID: 23208168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal Reflux Disease.
    Kellerman R; Kintanar T
    Prim Care; 2017 Dec; 44(4):561-573. PubMed ID: 29132520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heartburn: An underrecognized cause of PPI-refractory symptoms.
    Gabbard S; Vijayvargiya S
    Cleve Clin J Med; 2019 Dec; 86(12):799-806. PubMed ID: 31821137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
    Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
    Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
    Tack J; Fass R
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treat or investigate?
    Galmiche JP
    Eur J Gastroenterol Hepatol; 1999 Jun; 11 Suppl 1():S11-5. PubMed ID: 10443907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and treatment of GERD and upper GI complaints in athletes.
    Leggit JC
    Curr Sports Med Rep; 2011; 10(2):109-14. PubMed ID: 21623293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory Gastroesophageal Reflux Disease and Functional Heartburn.
    Spechler SJ
    Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):343-359. PubMed ID: 32146950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE).
    de Bortoli N; Penagini R; Savarino E; Marchi S
    Dig Liver Dis; 2017 Mar; 49(3):254-260. PubMed ID: 27979389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory gastroesophageal reflux disease.
    Moraes-Filho JP
    Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and management of gastroesophageal reflux disease.
    Rohof WO; Hirsch DP; Boeckxstaens GE
    Minerva Gastroenterol Dietol; 2009 Sep; 55(3):289-300. PubMed ID: 19829285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.